default author photo

Sankar Bhattacharya

Translational Health Science and Technology Institute

Faridabad, Haryana

India

  • Translational Health Science and Technology Institute

SCHOLARLY PAPERS

2

DOWNLOADS

826

TOTAL CITATIONS

6

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Cellular Immune Responses are Preserved and May Contribute to Chadox1 ChAdOx1 nCoV-19 Vaccine Effectiveness Against Infection Due to SARS-CoV-2 B·1·617·2 Delta Variant Despite Reduced Virus Neutralisation

Number of pages: 42 Posted: 16 Jul 2021
Ramachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, Sankar Bhattacharya, Shailendra Mani, Sridhar Sivasubbu, Tripti Srivatsava, Sweety Samal, Deepika Rathna Murugesan, Bapu Koundinya Desiraju, Pallavi Kshetrapal, Rajesh Pandey, Vinod Scaria, Praveen Kumar Malik, Juhi Taneja, Akshay Binayke, Tarini Vohra, Aymaan Zaheer, Deepak Rathore, Naseem Ahmed Khan, Heena Shaman, Shubbir Ahmed, Rajesh Kumar, Suprit Deshpande, Chandru Subramani, Nitya Wadhwa, Nimesh Gupta, Anil K. Pandey, Jayanta Bhattacharya, Anurag Agrawal, Sudhanshu Vrati, Shinjini Bhatnagar, Pramod Kumar Garg and DBT Consortium for COVID-19 Research
Translational Health Science and Technology Institute, Government of India - Immuno-biology Lab, Government of India - Translational Health Science & Technology Institute (THSTI), Translational Health Science and Technology Institute, Government of India - Infection and Immunology Center, CSIR-Institute of Genomics and Integrative Biology, Translational Health Science and Technology Institute, Government of India - Infection and Immunology Center, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, CSIR-Institute of Genomics and Integrative Biology, CSIR-Institute of Genomics and Integrative Biology, ESIC Medical College and Hospital, ESIC Medical College and Hospital, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Government of India - Vaccine and Infectious Disease Research Center, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Regional Center for Biotechnology, Translational Health Science and Technology Institute, National Institute of Immunology, ESIC Medical College and Hospital, Translational Health Science and Technology Institute, CSIR-Institute of Genomics and Integrative Biology, Regional Center for Biotechnology, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute and Independent
Downloads 826 (73,650)
Citation 6

Abstract:

Loading...

2.

Replication of Dengue Virus in K562-Megakaryocytes Suppresses Accumulation of Reactive Oxygen Species and Interferes with the Optimum Differentiation of Megakaryocyte Mother Cell

16TH VACCINE CONGRESS:P1.54
Posted: 19 Oct 2022
Neha Periwal, Vikas Sood, Jaskaran Kaur, Yogita Rawat, Deepak Rathore, Shrikant Kumar, Niraj Kumar, Sankar Bhattacharya and Milan Surjit
Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Translational Health Science & Technology Institute (THSTI), Translational Health Science and Technology Institute, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Translational Health Science & Technology Institute (THSTI), Translational Health Science and Technology Institute and affiliation not provided to SSRN

Abstract:

Loading...